Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants

Publication year - 2002

Publication title -

paediatrics and child health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.55

H-Index - 43

eISSN - 1918-1485

pISSN - 1205-7088

DOI - 10.1093/pch/7.1.20

Subject(s) - medicine , dexamethasone , lung disease , low birth weight , pediatrics , intensive care medicine , disease , lung , pregnancy , biology , genetics

This statement is intended for health care professionals caring for neonates and young infants. The objectives of this statement are to review the short and long term effects of systemic and inhaled postnatal corticosteroids for the prevention or treatment of evolving or established chronic lung disease, and to make recommendations for the use of corticosteroids in infants with very low birth weight. The routine use of systemic dexamethasone for the prevention or treatment of chronic lung disease in infants with very low birth weight is not recommended.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research